European Patent Organization

                   
genengnews.com: Genetic Engineering genengnews.com

AVANIR Announces Grant of New Zenvia Patent

genengnews.com     Jun 19, 2008   4 related          

News source: Business Wire AVANIR Pharmaceuticals today announced that the European Patent Office (EPO) has granted AVANIR a new patent, extending the period of commercial exclusivity for its lead drug candidate Zenvia(TM)...                    

comments

                   
bbc.co.uk: Thomas Edison, the inventor of the electric light bulb and phonograph bbc.co.uk

European Inventors Break Through

forbes.com     Jun 19, 2008   5 related          

LONDON - From Werner von Siemens to Gottlieb Daimler, Europe is a historical bastion for inventors who have founded some of the world's most powerful industrial firms. In Pictures: Notable European Inventors Considering their...                    

comments

In Pictures: Europe's Most Innovative Countries (at Forbes.com)

yahoo.com     Jun 19, 2008   5 related          

What's the recipe for innovation, and how do you measure how innovative a country is? A number of factors can determine the latter, including the number of scientists and engineers a country has and how much money the...                    

comments

ipnewsflash.com: IP Newsflash - hourly updated patent news ipnewsflash.com

CAFC: Tokyo Kikai Seisakusho v. U.S.

ipnewsflash.com     Jun 17, 2008          

found 4 h ago on www.cafc.uscourts.gov IP Newsflash is an IP meta-information portal that browses your information channels for you and presents only relevant, recent and customizable IP information on a single page. IP...                    

comments

                   

Great Finish in A Tough Competition for Chicago Patent Attorneys

prnewswire.com     Jun 16, 2008   5 related          

Great Finish in A Tough Competition for Chicago Patent Attorneys U.S. Team Takes 3rd in 2008 Patent Cup Sailing Race CHICAGO, June 16 /PRNewswire/ -- Co-skippers and patent attorneys, Gary M. Ropski, president of Brinks Hofer...                    

comments

                   

Arena Pharmaceuticals Presents Positive Phase 2a Clinical Trial Results Of APD125 For The...

pharmiweb.co.uk     Jun 14, 2008   8 related          

Previous Page Page 1 Next Page AVI BioPharma, Inc. Publishes Preclinical Data in Muscular Dystrophy Research Thursday, 12 Jun 2008 09:30am EDT AVI BioPharma, Inc. announced the publication of preclinical results of a study...                    

comments

                   

IBM System Triples Performance of HP in Critical Benchmark

webwire.com     Jun 12, 2008   9 related          

Power Systems Drive Customer Savings in Energy, Software and Floor Space - - - - - ARMONK, NY - Jun 2008: IBM (NYSE: IBM) announced today that a Power Systems™ server shattered another ... [WebWire - Thursday, June 12, 2008]                    

comments

ipnewsflash.com: IP Newsflash - hourly updated patent news ipnewsflash.com

BGH: I ZR 108/05, Entscheidung vom 05.06.2008

ipnewsflash.com     Jun 12, 2008   3 related          

found 2008-06-05 20:05:34 on juris.bundesgerichtshof.de IP Newsflash is an IP meta-information portal that browses your information channels for you and presents only relevant, recent and customizable IP information on a single...                    

comments

InNexus Biotechnology Announces Expansion of Patent Protection of DXL(TM) Technology

euroinvestor.co.uk     Jun 12, 2008          

InNexus Biotechnology Inc. (OTCBB:IXSBF) (TSX VENTURE:IXS) , a drug development company commercializing the next generation of monoclonal antibodies based on its technology, Dynamic Cross Linking (DXL™), announced today that it...                    

comments

Telik granted European patent for compounds related to Telintra

pharmaceutical-business-review.com     Jun 12, 2008   3 related          

Telik has announced that the European Patent Office has issued notices of allowance for two applications covering new compounds related to one of Telik's lead clinical candidates, Telintra. Telintra is currently in Phase II...                    

comments